Trending...
- UIFCA Revolutionizes Financial Education with Elite Team of Investment Experts
- CCHR Florida: Mental Health Awareness Month Open House
- Introducing LĪNA Universal Balm: A Luxury Multi-Use, Plant-Powered Solution for Skin & Hair
We are changing the MarTech world by protecting you from Big Tech's data abuse, and to celebrate the launch of AesirX BI & Analytics during this week, we are giving away $1 MILLION USD in LICENSES to the AesirX Community - contribute to the Giveaway for chances to win.
NEW YORK - PennZone -- 1280 CHANCES TO WIN!
As you know, AesirX always offers a FREEmium package for each of the 20 solutions released in our 2 year roadmap, so everyone is included and beyond, there are three more cost-effective tiers and a completely customizable Enterprise-level edition.
What if I told you that you could WIN these 4 APPEALING PACKAGES of AesirX BI & Analytics?
YES, AesirX is giving away 1280 exceptional rewards to the 1280 most active contributors.
What's more? The top rewards are 5 Enterprise-level packages with a 12-MONTH LICENSE valued at $12,000 USD each.
1280 chances to win
Click HERE to WIN.
Winners will be notified via email. GIVEAWAY starts
How to win
Make sure you UPVOTE on Product Hunt to win!
Step 1:
Step 2:
Step 3: Do the other activities to gain more points. (Visit AesirX on Facebook, Follow us on LinkedIn, etc.)
ALERT!!!
YOU EARN MORE CHANCES TO WIN by joining our community (follow/subscribe) and giving us a lot of love on these platforms:
Join us and win a bundle high-quality licenses for your next adventure with AesirX solutions!
More on The PennZone
As you know, AesirX always offers a FREEmium package for each of the 20 solutions released in our 2 year roadmap, so everyone is included and beyond, there are three more cost-effective tiers and a completely customizable Enterprise-level edition.
What if I told you that you could WIN these 4 APPEALING PACKAGES of AesirX BI & Analytics?
YES, AesirX is giving away 1280 exceptional rewards to the 1280 most active contributors.
What's more? The top rewards are 5 Enterprise-level packages with a 12-MONTH LICENSE valued at $12,000 USD each.
1280 chances to win
Name | License per month | License value total 1 year | Amount | Total value |
Starter | $49 | $588 | 1000 | $588,000 |
Team | $99 | $1,188 | 250 | $297,000 |
Growth | $249 | $2,988 | 25 | $74,700 |
Enterprise | $1,000 | $12,000 | 5 | $60,000 |
More on The PennZone
Total Giveaway licenses | 1280 | $1,019,700 |
Click HERE to WIN.
Winners will be notified via email. GIVEAWAY starts
- from 21st November 12:00 AM PST
- to 28th November 12:00 AM PST
How to win
Make sure you UPVOTE on Product Hunt to win!
Step 1:
- Enter Gleam: https://gleam.io/cYdeW/vote-on-product-hunt-1-million-usd-aesirx-license-giveaway
- Log in with your Email/ Facebook/ Instagram/ Twitter account.
Step 2:
- Click on 'Vote for AesirX Business Intelligence on Product Hunt'
- Click on 'Vote for AesirX Analytics on Product Hunt'
- Upvote for both on PRODUCT HUNT
Step 3: Do the other activities to gain more points. (Visit AesirX on Facebook, Follow us on LinkedIn, etc.)
ALERT!!!
YOU EARN MORE CHANCES TO WIN by joining our community (follow/subscribe) and giving us a lot of love on these platforms:
- Twitter: https://twitter.com/aesirxio
- Instagram: https://www.instagram.com/aesirxio/
- Youtube: https://www.youtube.com/@aesirxio
- Telegram: https://t.me/aesirxio
- GitHub Main: https://github.com/aesirxio
Join us and win a bundle high-quality licenses for your next adventure with AesirX solutions!
More on The PennZone
- Actuated Medical Launches Participating Preferred Series A Round, Led by Keiretsu Forum Mid-Atlantic, South-East, & Texas
- ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
- Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
Source: Aesirx.io Ltd.
0 Comments
Latest on The PennZone
- Braces for Teenagers in Allentown Offered by Exeter Smiles
- Roots for Boots to Host "Bike Day Bash" Featuring Trike Presentation to Local Veteran
- JOSHWAY Cuts Ribbon on New Brick-and-Mortar Location
- ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- Children's Hospital of Philadelphia Researchers Recommend New Standard of Care for Families with Hereditary Neuroblastoma Linked to ALK Mutation
- GormanSquared Announces Provisional Patent
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- Chewy Chums™ Launches NeverBite™ on Kickstarter
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
- Fangzhou Launches Otsuka's Third-Generation Leukemia Drug Ponatinib on its Platform
- Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
- Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Whistleblower Claims Dental Patient Deaths Likely Due to Book Ban